Stay updated on GSK3145095 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GSK3145095 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GSK3145095 Combo in Advanced Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe Study Details page shows no additions or deletions; the study information, eligibility criteria, and locations appear unchanged.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.SummaryDifference0.8%

- Check39 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.0%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.0%

- Check68 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several specific location details and resources related to pembrolizumab have been removed.SummaryDifference0.4%

Stay in the know with updates to GSK3145095 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK3145095 Combo in Advanced Solid Tumors Clinical Trial page.